Scientists a step closer to drug treatment for Hepatitis B

A major new insight into how Hepatitis B Virus works could pave the way for new drug treatments for the infection which is the major cause of liver cancer worldwide. The team at the Universities of Leeds and York identified an ‘assembly code’ in the genetic material of Hepatitis B Virus that allows it to create a protective casing in which it can produce new infectious virus particles.

Read the full press release here

Read HBV RNA pre-genome encodes specific motifs that mediate interactions with the viral core protein that promote nucleocapsid assembly published in Nature Microbiology